Innate Pharma Market Cap

Innate Pharma has a market cap or net worth of 149.03 million as of May 15, 2025. Its market cap has decreased by -6.33% in one year.

Market Cap

149.03M

Enterprise Value

107.11M

Revenue

16.64M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.94

Market Cap Chart

Since November 1, 2006, Innate Pharma's market cap has increased from 530.53K to 149.03M, an increase of 27,991.77%. That is a compound annual growth rate of 35.52%.

Market Cap History

Date	Market Cap	% Change
May 15, 2025	149.03M	12.68%
Dec 31, 2024	132.26M	-27.85%
Dec 29, 2023	183.31M	-21.67%
Dec 30, 2022	234.02M	-20.77%
Dec 31, 2021	295.36M	20.59%
Dec 31, 2020	244.93M	-38.25%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	155.40B
HSBC Holdings	153.32B
Shell	150.74B
Unilever	113.95B
Rio Tinto Group	80.56B
RELX PLC	72.63B
Rolls-Royce Holdings	67.02B
British American Tobacco p.l.c.	66.33B

Market Cap Rankings